| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 701 | 14.387 | 16.721 | - | - | 11.848 | 26.531 | 162.435 | - | - |
| Total Income - EUR | 701 | 14.390 | 16.724 | - | - | 13.372 | 26.539 | 177.639 | - | - |
| Total Expenses - EUR | 1.006 | 6.365 | 13.578 | - | - | 16.763 | 15.951 | 81.588 | - | - |
| Gross Profit/Loss - EUR | -305 | 8.025 | 3.146 | - | - | -3.391 | 10.588 | 96.050 | - | - |
| Net Profit/Loss - EUR | -326 | 7.593 | 2.644 | - | - | -3.792 | 9.792 | 91.927 | - | - |
| Employees | 0 | 0 | 0 | - | - | 0 | 0 | 0 | - | - |
Check the financial reports for the company - Bioprosano Natura Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.211 | 2.812 | 2.404 | - | - | 1.248 | 888 | 51.553 | - | - |
| Current Assets | 446 | 5.236 | 8.771 | - | - | 38.251 | 46.522 | 123.795 | - | - |
| Inventories | 0 | 4.526 | 2.745 | - | - | 0 | 0 | 0 | - | - |
| Receivables | 20 | 23 | 804 | - | - | 24.028 | 35.639 | 64.186 | - | - |
| Cash | 426 | 687 | 5.222 | - | - | 14.224 | 10.883 | 59.608 | - | - |
| Shareholders Funds | -281 | 7.315 | 9.835 | - | - | 31.315 | 40.322 | 132.347 | - | - |
| Social Capital | 45 | 45 | 44 | - | - | 41 | 40 | 41 | - | - |
| Debts | 3.938 | 733 | 1.340 | - | - | 8.185 | 7.088 | 43.000 | - | - |
| Income in Advance | 0 | 0 | 0 | - | - | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Bioprosano Natura Srl